Literature DB >> 21976651

Microvesicles and viral infection.

David G Meckes1, Nancy Raab-Traub.   

Abstract

Cells secrete various membrane-enclosed microvesicles from their cell surface (shedding microvesicles) and from internal, endosome-derived membranes (exosomes). Intriguingly, these vesicles have many characteristics in common with enveloped viruses, including biophysical properties, biogenesis, and uptake by cells. Recent discoveries describing the microvesicle-mediated intercellular transfer of functional cellular proteins, RNAs, and mRNAs have revealed additional similarities between viruses and cellular microvesicles. Apparent differences include the complexity of viral entry, temporally regulated viral expression, and self-replication proceeding to infection of new cells. Interestingly, many virally infected cells secrete microvesicles that differ in content from their virion counterparts but may contain various viral proteins and RNAs. For the most part, these particles have not been analyzed for their content or functions during viral infection. However, early studies of microvesicles (L-particles) secreted from herpes simplex virus-infected cells provided the first evidence of microvesicle-mediated intercellular communication. In the case of Epstein-Barr virus, recent evidence suggests that this tumorigenic herpesvirus also utilizes exosomes as a mechanism of cell-to-cell communication through the transfer of signaling competent proteins and functional microRNAs to uninfected cells. This review focuses on aspects of the biology of microvesicles with an emphasis on their potential contributions to viral infection and pathogenesis.

Entities:  

Mesh:

Year:  2011        PMID: 21976651      PMCID: PMC3233125          DOI: 10.1128/JVI.05853-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  172 in total

1.  Protein targeting to exosomes/microvesicles by plasma membrane anchors.

Authors:  Beiyi Shen; Ning Wu; Jr-Ming Yang; Stephen J Gould
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

2.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

Review 3.  Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'.

Authors:  Tae Hoon Lee; Esterina D'Asti; Nathalie Magnus; Khalid Al-Nedawi; Brian Meehan; Janusz Rak
Journal:  Semin Immunopathol       Date:  2011-02-12       Impact factor: 9.623

4.  Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells.

Authors:  A Sanfridson; S Hester; C Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

5.  Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.

Authors:  Kei Sato; Jun Aoki; Naoko Misawa; Eriko Daikoku; Kouichi Sano; Yuetsu Tanaka; Yoshio Koyanagi
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

6.  Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia.

Authors:  A F Orozco; C J Jorgez; W D Ramos-Perez; E J Popek; X Yu; C A Kozinetz; F Z Bischoff; D E Lewis
Journal:  Placenta       Date:  2009-08-18       Impact factor: 3.481

7.  The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.

Authors:  A Ginestra; M D La Placa; F Saladino; D Cassarà; H Nagase; M L Vittorelli
Journal:  Anticancer Res       Date:  1998 Sep-Oct       Impact factor: 2.480

8.  Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation.

Authors:  Richard Wubbolts; Rachel S Leckie; Peter T M Veenhuizen; Guenter Schwarzmann; Wiebke Möbius; Joerg Hoernschemeyer; Jan-Willem Slot; Hans J Geuze; Willem Stoorvogel
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

9.  Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells.

Authors:  Claudia Muratori; Lucas E Cavallin; Kirsten Krätzel; Antonella Tinari; Angelo De Milito; Stefano Fais; Paola D'Aloja; Maurizio Federico; Vincenzo Vullo; Alla Fomina; Enrique A Mesri; Fabiana Superti; Andreas S Baur
Journal:  Cell Host Microbe       Date:  2009-09-17       Impact factor: 21.023

10.  Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane.

Authors:  Amy M Booth; Yi Fang; Jonathan K Fallon; Jr-Ming Yang; James E K Hildreth; Stephen J Gould
Journal:  J Cell Biol       Date:  2006-03-13       Impact factor: 10.539

View more
  196 in total

1.  Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo.

Authors:  Prachi P Singh; Victoria L Smith; Petros C Karakousis; Jeffery S Schorey
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

2.  Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.

Authors:  Zhen Lin; Kenneth Swan; Xin Zhang; Subing Cao; Zoe Brett; Stacy Drury; Michael J Strong; Claire Fewell; Adriane Puetter; Xia Wang; MaryBeth Ferris; Deborah E Sullivan; Li Li; Erik K Flemington
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

Review 3.  The Function of TrophomiRs and Other MicroRNAs in the Human Placenta.

Authors:  Yoel Sadovsky; Jean-Francois Mouillet; Yingshi Ouyang; Avraham Bayer; Carolyn B Coyne
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

Review 4.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

5.  Tetraspanin CD63 Bridges Autophagic and Endosomal Processes To Regulate Exosomal Secretion and Intracellular Signaling of Epstein-Barr Virus LMP1

Authors:  Stephanie N Hurwitz; Mujeeb R Cheerathodi; Dingani Nkosi; Sara B York; David G Meckes
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

Authors:  Danyang Gong; Xinghong Dai; Yuchen Xiao; Yushen Du; Travis J Chapa; Jeffrey R Johnson; Xinmin Li; Nevan J Krogan; Hongyu Deng; Ting-Ting Wu; Ren Sun
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 7.  Intercellular transport of microRNAs.

Authors:  Reinier A Boon; Kasey C Vickers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

8.  Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.

Authors:  Elizabeth Jaworski; Aarthi Narayanan; Rachel Van Duyne; Shabana Shabbeer-Meyering; Sergey Iordanskiy; Mohammed Saifuddin; Ravi Das; Philippe V Afonso; Gavin C Sampey; Myung Chung; Anastas Popratiloff; Bindesh Shrestha; Mohit Sehgal; Pooja Jain; Akos Vertes; Renaud Mahieux; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

9.  Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.

Authors:  Amanda L Treece; Daniel L Duncan; Weihua Tang; Sandra Elmore; Douglas R Morgan; Ricardo L Dominguez; Olga Speck; Michael O Meyers; Margaret L Gulley
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

10.  MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.

Authors:  Claudia Goettsch; Joshua D Hutcheson; Elena Aikawa
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.